VOYA INVESTMENT MANAGEMENT LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,125,633
-84.5%
82,167
-62.9%
0.00%
-83.3%
Q2 2023$20,170,814
+12.4%
221,414
-18.6%
0.02%
+4.3%
Q1 2023$17,938,282
+119.5%
271,957
+72.0%
0.02%
+91.7%
Q4 2022$8,174,161
-27.6%
158,077
-4.4%
0.01%
-25.0%
Q3 2022$11,292,039
+107.1%
165,330
+37.1%
0.02%
+14.3%
Q2 2022$5,452,000
+11.8%
120,572
+25.6%
0.01%
+40.0%
Q1 2022$4,878,000
-0.7%
96,009
-7.6%
0.01%
+11.1%
Q4 2021$4,911,000
+492.4%
103,876
+313.1%
0.01%
+350.0%
Q3 2021$829,000
-48.5%
25,144
-1.3%
0.00%
-33.3%
Q2 2021$1,610,000
+41.2%
25,481
-4.1%
0.00%
+50.0%
Q1 2021$1,140,000
-24.5%
26,559
+0.7%
0.00%
-33.3%
Q4 2020$1,509,000
+105.3%
26,378
+8.2%
0.00%
+50.0%
Q3 2020$735,000
+7.9%
24,378
+16.9%
0.00%0.0%
Q2 2020$681,000
-9.9%
20,857
-26.1%
0.00%0.0%
Q1 2020$756,000
+3.0%
28,234
+17.7%
0.00%0.0%
Q4 2019$734,000
+62.7%
23,987
+28.1%
0.00%
+100.0%
Q3 2019$451,000
-5.1%
18,7260.0%0.00%0.0%
Q2 2019$475,000
+62.1%
18,726
+24.5%
0.00%0.0%
Q1 2019$293,000
+41.5%
15,036
-4.4%
0.00%0.0%
Q4 2018$207,000
-17.5%
15,720
+11.5%
0.00%0.0%
Q3 2018$251,000
-19.0%
14,0990.0%0.00%0.0%
Q2 2018$310,00014,0990.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders